← back to search

Xinran Wang

Beijing Technology and Business University · CN
Area of research
Oncology · Psychiatry and Mental health
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Dementia and Cognitive Impairment Research, Pressure Ulcer Prevention and Management, and Alzheimer's disease research and treatments.
h-index
16
citations
1,722
works
99
NIH funding
primary concept
email

Recent publications

Sivelestat sodium protects against renal ischemia/reperfusion injury by reduction of NETs formation
Archives of Biochemistry and Biophysics 2025cited by 14position: middledoi
Current Status of Immune Checkpoint Inhibitors and Treatment Responsive Biomarkers for Triple‐Negative Breast Cancer
Thoracic Cancer 2025cited by 4position: firstdoi
<scp>SAA1</scp> as a Potential Early Diagnostic Biomarker for Sepsis Through Integrated Proteomics and Metabolomics
Immunology 2025cited by 2position: middledoi
Urine Neutrophil Elastase: A Novel Predictor of ICU Admission for Patients with COVID-19 Infection
Journal of Inflammation Research 2025cited by 1position: middledoi
Dynamic changes in the real-time glomerular filtration rate and kidney injury markers in different acute kidney injury models
Journal of Translational Medicine 2024cited by 16position: middledoi
Navigating the gut-bone axis: The pivotal role of Coprococcus3 in osteoporosis prevention through Mendelian randomization
Medicine 2024cited by 3position: middledoi
Dynamic changes in the real-time glomerular filtration rate and kidney injury markers in different acute kidney injury models
Research Square 2024cited by 2position: middledoi
Prognostic factors of patients with human epidermal growth factor receptor 2-positive breast cancer following neoadjuvant therapy: Development and validation of a predictive nomogram
Pathology - Research and Practice 2024cited by 0position: middledoi
Evolving trends in drug overdose mortality in the USA from 2000 to 2020: an age-period-cohort analysis
EClinicalMedicine 2023cited by 30position: middledoi
To investigate the prognostic factors of stage Ⅰ-Ⅱ gastric cancer based on P53 mutation and tumor budding
Pathology - Research and Practice 2022cited by 7position: middledoi
Relationship between the Volume Ratio of Subchorionic Hematoma to Gestation SAC in First-trimester and Pregnancy Outcome of Patients with Threatened Abortion
Journal of College of Physicians And Surgeons Pakistan 2022cited by 6position: firstdoi
Delineation of Target Volumes of Neoadjuvant Radiation in Esophageal Squamous Cell Cancer in China: A Consensus Proposal
Research Square 2022cited by 0position: middledoi
Prognostic implications of stromal tumor-infiltrating lymphocytes and programmed death ligand 1 expression in HER2-positive invasive breast cancer
2020cited by 0position: firstdoi
Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome
Cell Metabolism 2019cited by 882position: middledoi
PD-L1 expression in tumor infiltrated lymphocytes predicts survival in triple-negative breast cancer
Pathology - Research and Practice 2019cited by 47position: firstdoi
Clinicopathological features and risk factors of lymph node metastasis of gastrointestinal neuroendocrine neoplasms in 467 patients
Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi 2017cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yueping Liu · Hebei Medical University5 papers (2019–2025)Yanqi Liu · Tianjin University of Traditional Chinese Medicine4 papers (2024–2025)Hongxu Li · Harbin Medical University4 papers (2024–2025)Kaijiang Yu · Brigham and Women's Hospital4 papers (2024–2025)Changsong Wang · Nanchang University4 papers (2024–2025)Yuhan Liu · Nanchang University4 papers (2024–2025)Yu Xiao · Harbin Medical University3 papers (2024–2025)Yuchen Song · Harbin Medical University3 papers (2024–2025)Yu Xin · Harbin Medical University3 papers (2024–2025)Yuxin Zhou · Harbin Medical University3 papers (2024–2025)Xibo Wang · University of Vermont3 papers (2024–2025)Linqiong Liu · Harbin Medical University3 papers (2024–2025)Pengfei Huang · Harbin Medical University3 papers (2024–2025)Mengyao Yuan · University of Edinburgh3 papers (2024–2025)Yuxi Liu · Shanghai Medical College of Fudan University2 papers (2024–2025)Dawei Wang · Rush University Medical Center2 papers (2024–2024)Yahui Peng · Harbin Medical University2 papers (2024–2024)Yinghao Luo · Harbin Medical University2 papers (2025–2025)Lifeng Shen · Harbin Medical University2 papers (2024–2025)Yu‐Chen Song · Harbin Medical University1 papers (2025–2025)